First Trust Indxx Global Medical Devices ETF Price & Performance (MDEV)

Exchange-traded funds (ETFs) remain a strong investment choice in 2025, with diverse sectors showing significant returns. Among the top performers, healthcare-focused ETFs like iShares U.S. Medical Devices ETF and ARK Genomic Revolution ETF have gained traction, reflecting investor interest in innovative sectors like biotechnology and medical devices.1

Robert F. Kennedy Jr.'s appointment as Health Secretary has raised concerns over potential NIH funding cuts. Analysts warn that reduced grants may destabilize research-driven healthcare companies. This uncertainty could impact stocks like Pfizer and Moderna, as well as sector-specific ETFs, amid rising healthcare costs and pandemic fears.2

West Pharmaceutical Services faces challenges with a 32.8% YTD stock decline, underperforming broader markets. Despite weak guidance for 2025, analysts remain optimistic, with nine out of ten rating it a 'Strong Buy.' The company’s innovative drug packaging solutions and potential upside continue to attract investor interest.3